Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989;28(Suppl 2):177S–182S. doi: 10.1111/j.1365-2125.1989.tb03593.x

Angiotensin converting enzyme inhibition and cerebral circulation—a review

G Waldemar, O B Paulson
PMCID: PMC1379863  PMID: 2690908

Abstract

1 The identification of a vascular wall renin angiotensin system and of angiotensin converting enzyme on the luminal surface of the endothelium in many tissues, including the brain, has stimulated research on the influence of the renin angiotensin system on regional blood flows.

2 In experimental studies inhibition of the angiotensin converting enzyme shifts the limits of cerebral blood flow autoregulation towards lower blood pressure values.

3 In patients with chronic arterial hypertension and in patients with chronic heart failure cerebral blood flow is not changed by acute or chronic angiotensin converting enzyme inhibition, despite in some cases pronounced reductions in the mean arterial blood pressure. Angiotensin converting enzyme inhibition does not change ischaemic regional cerebral blood flow in acute stroke.

4 It is concluded that following angiotensin converting inhibition cerebral blood flow is maintained at an unchanged level. The mechanism may include inhibition of locally produced angiotensin II leading to a selective dilation of larger cerebral arteries with a compensatory constriction of the smaller cerebral arteries.

Keywords: angiotensin II, angiotensin converting enzyme, autoregulation, cerebral blood flow

Full text

PDF
177S

Images in this article

180SFigure 3
on p.180S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry D. I., Jarden J. O., Paulson O. B., Graham D. I., Strandgaard S. Cerebrovascular aspects of converting-enzyme inhibition I: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats. J Hypertens. 1984 Dec;2(6):589–597. doi: 10.1097/00004872-198412000-00003. [DOI] [PubMed] [Google Scholar]
  2. Barry D. I., Strandgaard S., Graham D. I., Braendstrup O., Svendsen U. G., Vorstrup S., Hemmingsen R., Bolwig T. G. Cerebral blood flow in rats with renal and spontaneous hypertension: resetting of the lower limit of autoregulation. J Cereb Blood Flow Metab. 1982 Sep;2(3):347–353. doi: 10.1038/jcbfm.1982.35. [DOI] [PubMed] [Google Scholar]
  3. Bouthier J. D., Safar M. E., Benetos A., Simon A. C., Levenson J. A., Hugues C. M. Haemodynamic effects of vasodilating drugs on the common carotid and brachial circulations of patients with essential hypertension. Br J Clin Pharmacol. 1986 Feb;21(2):137–142. doi: 10.1111/j.1365-2125.1986.tb05167.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brunner H. R., Nussberger J., Waeber B. Effects of angiotensin converting enzyme inhibition: a clinical point of view. J Cardiovasc Pharmacol. 1985;7 (Suppl 4):S73–S81. doi: 10.1097/00005344-198507004-00015. [DOI] [PubMed] [Google Scholar]
  5. Dzau V. J., Colucci W. S., Williams G. H., Curfman G., Meggs L., Hollenberg N. K. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med. 1980 Jun 19;302(25):1373–1379. doi: 10.1056/NEJM198006193022501. [DOI] [PubMed] [Google Scholar]
  6. Dzau V. J., Ingelfinger J., Pratt R. E., Ellison K. E. Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains. Hypertension. 1986 Jun;8(6):544–548. doi: 10.1161/01.hyp.8.6.544. [DOI] [PubMed] [Google Scholar]
  7. Dzau V. J. Vascular renin-angiotensin system in hypertension. New insights into the mechanism of action of angiotensin converting enzyme inhibitors. Am J Med. 1988 Apr 15;84(4A):4–8. doi: 10.1016/0002-9343(88)90463-9. [DOI] [PubMed] [Google Scholar]
  8. Dzau V. J. Vascular wall renin-angiotensin pathway in control of the circulation. A hypothesis. Am J Med. 1984 Oct 5;77(4A):31–36. doi: 10.1016/s0002-9343(84)80035-2. [DOI] [PubMed] [Google Scholar]
  9. Edvinsson L., Owman C., Siesjö B. Physiological role of cerebrovascular sympathetic nerves in the autoregulation of cerebral blood flow. Brain Res. 1976 Dec 3;117(3):519–523. doi: 10.1016/0006-8993(76)90760-5. [DOI] [PubMed] [Google Scholar]
  10. Erdös E. G., Skidgel R. A. The angiotensin I-converting enzyme. Lab Invest. 1987 Apr;56(4):345–348. [PubMed] [Google Scholar]
  11. Frei A., Müller-Brand J. Cerebral blood flow and antihypertensive treatment with enalapril. J Hypertens. 1986 Jun;4(3):365–367. doi: 10.1097/00004872-198606000-00018. [DOI] [PubMed] [Google Scholar]
  12. Ganten D., Hermann K., Unger T., Lang R. E. The tissue renin-angiotensin systems: focus on brain angiotensin, adrenal gland and arterial wall. Clin Exp Hypertens A. 1983;5(7-8):1099–1118. doi: 10.3109/10641968309048844. [DOI] [PubMed] [Google Scholar]
  13. Jarden J. O., Barry D. I., Juhler M., Graham D. I., Strandgaard S., Paulson O. B. Cerebrovascular aspects of converting-enzyme inhibition II: Blood-brain barrier permeability and effect of intracerebroventricular administration of captopril. J Hypertens. 1984 Dec;2(6):599–604. doi: 10.1097/00004872-198412000-00004. [DOI] [PubMed] [Google Scholar]
  14. Mendelsohn F. A. Localization and properties of angiotensin receptors. J Hypertens. 1985 Aug;3(4):307–316. doi: 10.1097/00004872-198508000-00002. [DOI] [PubMed] [Google Scholar]
  15. Minematsu K., Yamaguchi T., Tsuchiya M., Ito K., Ikeda M., Omae T. Effect of angiotensin converting enzyme inhibitor (captopril) on cerebral blood flow in hypertensive patients without a history of stroke. Clin Exp Hypertens A. 1987;9(2-3):551–557. doi: 10.3109/10641968709164223. [DOI] [PubMed] [Google Scholar]
  16. Paulson O. B., Jarden J. O., Vorstrup S., Holm S., Godtfredsen J. Effect of captopril on the cerebral circulation in chronic heart failure. Eur J Clin Invest. 1986 Apr;16(2):124–132. doi: 10.1111/j.1365-2362.1986.tb01319.x. [DOI] [PubMed] [Google Scholar]
  17. Richer C., Doussau M. P., Giudicelli J. F. Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat. Am J Cardiol. 1987 Apr 24;59(10):12D–17D. doi: 10.1016/0002-9149(87)90046-4. [DOI] [PubMed] [Google Scholar]
  18. Roberts D. H., Tsao Y., McLoughlin G. A., Breckenridge A. Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication. Lancet. 1987 Sep 19;2(8560):650–653. doi: 10.1016/s0140-6736(87)92441-x. [DOI] [PubMed] [Google Scholar]
  19. Strandgaard S. Autoregulation of cerebral circulation in hypertension. Acta Neurol Scand Suppl. 1978;66:1–82. [PubMed] [Google Scholar]
  20. Swales J. D., Thurston H. Generation of angiotensin II at peripheral vascular level: studies using angiotensin II antisera. Clin Sci Mol Med. 1973 Nov;45(5):691–700. doi: 10.1042/cs0450691. [DOI] [PubMed] [Google Scholar]
  21. Takeyama K., Minato H., Nakatsuji K., Suzuki H., Nose I., Oka M., Hosoki K., Hatano N., Kadokawa T. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals. Arzneimittelforschung. 1986;36(1):69–73. [PubMed] [Google Scholar]
  22. Vorstrup S., Barry D. I., Jarden J. O., Svendsen U. G., Braendstrup O., Graham D. I., Strandgaard S. Chronic antihypertensive treatment in the rat reverses hypertension-induced changes in cerebral blood flow autoregulation. Stroke. 1984 Mar-Apr;15(2):312–318. doi: 10.1161/01.str.15.2.312. [DOI] [PubMed] [Google Scholar]
  23. Wahl M., Young A. R., Edvinsson L., Wagner F. Effects of kininase II inhibitors on the vasomotor response to bradykinin of feline intracranial and extracranial arteries in vitro and in situ. J Cereb Blood Flow Metab. 1983 Sep;3(3):339–345. doi: 10.1038/jcbfm.1983.49. [DOI] [PubMed] [Google Scholar]
  24. Whalley E. T., Wahl M. Cerebrovascular reactivity to angiotensin and angiotensin-converting enzyme activity in cerebrospinal fluid. Brain Res. 1988 Jan 12;438(1-2):1–7. doi: 10.1016/0006-8993(88)91318-2. [DOI] [PubMed] [Google Scholar]
  25. Whalley E. T., Wahl M. The effect of kininase II inhibitors on the response of feline cerebral arteries to bradykinin and angiotensin. Pflugers Arch. 1983 Jul;398(2):175–177. doi: 10.1007/BF00581069. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES